Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc. to December 16, 2019

    NEXT STORY
    Genomics Market to Exhibit a Stellar CAGR of 18.7%, Demand for Genomic Products to Augment Owing to Increasing Number of Product Launches: Fortune Business Insights
    PREV STORY
    Changes in the Board of Directors and the Corporate Executive Committee of Roche
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Telix Pharmaceuticals and Atlab Pharma Conclude Therapeutic Product Development Agreement for Prostate Cancer

    MELBOURNE, Australia and NANTES, France, Jan. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited ...

    author_avatar
    NASDAQ Market News

    Orthopedic Implants Market Size to Reach US $64 Billion by 2026; Rising Number of Orthopedic Sports Injuries to Favor Growth

    author_avatar
    NASDAQ Market News

    Precision Therapeutics, Formerly Skyline Medical, Announces Stock Ticker Symbol Change to AIPT

    MINNEAPOLIS, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc, formerly Skyline Medical Inc, ...

    author_avatar
    NASDAQ Market News